FDA Inspection 954660 — AstraZeneca Pharmaceuticals, LP
The FDA completed an inspection of AstraZeneca Pharmaceuticals, LP on December 18, 2015 in Coppell, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 18, 2015
- Fiscal Year
- 2016
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Coppell, TX (United States)
Additional Details
Sponsor, Contract Research Organization